BGI, Roche roll out diagnostic tests for Alzheimer's in China

Core Insights - BGI Genomics and Roche Diagnostics have launched Alzheimer's disease tests in China to enhance access to user-friendly diagnostic and monitoring options for patients [1] Company Developments - BGI Genomics and Roche Diagnostics are collaborating to provide new testing solutions for Alzheimer's disease in the Chinese market [1] Industry Trends - The introduction of these tests reflects a growing trend in the healthcare industry towards improving diagnostic capabilities and patient monitoring for neurodegenerative diseases [1]